Dasatinib In Waldenström Macroglobulinemia
Clinical trial NCT04115059 · TERMINATED
Trial details
- NCT number
- NCT04115059
- Sponsor
- Jorge J. Castillo, MD
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2021-12-31
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.